REVVITY, INC Accrued Income Taxes
REVVITY, INC (RVTY) had Accrued Income Taxes of $80.56 million as of 2025-12-28, per its 10-K filed 2026-02-24.
Financial Statements › Balance Sheet › Liabilities › Accrued Liabilities
us-gaap:AccruedIncomeTaxes · last filed 2026-02-24
- 2025-12-28: Accrued Income Taxes $80.56M.
- 2024-12-29: Accrued Income Taxes $74.40M.
- 2023-12-31: Accrued Income Taxes $88.16M.
- 2023-01-01: Accrued Income Taxes $45.63M.
| Period end | Accrued Income Taxes | Accrued Income Taxes as first filed |
|---|---|---|
| 2025-12-28 | $80.56M 10-K · filed 2026-02-24 | |
| 2024-12-29 | $74.40M 10-K · filed 2026-02-24 | |
| 2023-12-31 | $88.16M 10-K · filed 2025-02-25 | |
| 2023-01-01 | $45.63M 10-K · filed 2024-02-27 | |
| 2022-01-02 | $88.28M 10-K · filed 2023-03-01 | $90.96M 10-K · filed 2022-03-03 |
| 2021-01-03 | $97.41M 10-K · filed 2022-03-03 | |
| 2019-12-29 | $29.88M 10-K · filed 2021-03-02 | |
| 2018-12-30 | $30.69M 10-K · filed 2020-02-25 | |
| 2017-12-31 | $10.80M 10-K · filed 2019-02-26 | |
| 2017-01-01 | $8.19M 10-K · filed 2018-02-27 | |
| 2016-01-03 | $2.88M 10-K · filed 2017-02-28 | |
| 2014-12-28 | $9.80M 10-K · filed 2016-03-01 | |
| 2013-12-29 | $11.78M 10-K · filed 2015-02-24 | |
| 2012-12-30 | $16.09M 10-K · filed 2014-02-25 | |
| 2012-01-01 | $36.54M 10-K · filed 2013-02-26 | |
| 2011-01-02 | $24.43M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |